Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alteon (ALT) -- Ignore unavailable to you. Want to Upgrade?

To: The Gambler who wrote (221)	3/1/1998 5:57:00 PM
From: Bill Tomko	Read Replies (1) \| Respond to of 318

believe it or not the number I have seen is $30.00! WHile I certainly hope so, N.B. research is to be sold from not bought from! That said, subject to outcome of the Action I and next year the Action II followed by ESRD in 2000. I do believe over a couple of years and subject to some follow on SUCESSFUL clinical on cross link breakers, this could be a $100.00 stock 2- 4 years out. This is based upon the size of the targeted market, aging population. I honestly believe subject to a long assumption of sucessful clinical and follow on products ALTN could be an AMGN.